By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PaxVax, Inc. 

1331 Hillview Drive

Menlo Park  California  94025  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
PaxVax, Inc. Announces Primary Endpoints Met In Phase 3 Cholera Vaccine Trial 12/8/2014 2:31:41 PM
Specialty Vaccine Company PaxVax, Inc. To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014 9:52:58 AM
Specialty Vaccine Company PaxVax, Inc. Appoints Mark Meltz Executive Vice President And Chief Legal Officer 9/3/2014 10:26:35 AM
Specialty Vaccine Company PaxVax, Inc. Expands Global Commercial Team 8/7/2014 10:52:40 AM
Specialty Vaccine Company PaxVax, Inc. Expands Global Commercial Team 8/7/2014 9:47:34 AM
PaxVax, Inc. Acquires FDA-Approved Typhoid Vaccine Vivotif 7/28/2014 8:54:00 AM
Bay Area's PaxVax, Inc. Reels In Up To $60 Million Financing 7/28/2014 5:55:42 AM
Specialty Vaccine Company PaxVax, Inc. Announces Positive Efficacy Results For Phase 3 Cholera Challenge Study 7/1/2014 11:00:25 AM
PaxVax, Inc. Signs R&D Collaboration With University of California, San Diego (UCSD) To Develop A Vaccine To Prevent Herpes Simplex Virus Infections 6/10/2014 9:43:54 AM
Specialty Vaccine Company PaxVax, Inc. To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/27/2014 7:54:24 AM
123
//-->